Wei Jin

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Ejection Fraction

Brain Metastases

Top Venues

Disease markers

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
Baojin Xu, Hefen Sun, Simeng Liu, Li Liao, Xiaoqing Song, Yi Wu, Yifeng Hou, Wei Jin
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene 43 (10) (2024)
He-Fen Sun, Liang-Dong Li, I-Weng Lao, Xuan Li, Bao-Jin Xu, Yi-Qun Cao, Wei Jin
Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases. Clinical and translational medicine 12 (11) (2022)
Qiqi Liu, Hefen Sun, Yang Liu, Xuan Li, Baojin Xu, Liangdong Li, Wei Jin
HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-β Canonical and Noncanonical Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (12) (2022)
Yuanyuan Zhao, Hefen Sun, Xuan Li, Qiqi Liu, Yang Liu, Yifeng Hou, Wei Jin
DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2. Cell death & disease 13 (2) (2022)
Yang Zhao, Hefen Sun, Yuanyuan Zhao, Qiqi Liu, Yang Liu, Yifeng Hou, Wei Jin
NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/TβR1/EMT axis. Oncogene 41 (25) (2022)
Mengting Chen, Yang Zhao, Xueli Yang, Yuanyuan Zhao, Qiqi Liu, Yang Liu, Yifeng Hou, Hefen Sun, Wei Jin
NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis. Breast cancer research and treatment 187 (2) (2021)
Liangdong Li, Yang Bai, Yang Gao, Deheng Li, Lei Chen, Changshuai Zhou, Mingtao Feng, Xin Chen, Wei Jin, Yiqun Cao
Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. Disease markers 2021 (2021)
Qi-Qi Liu, He-Fen Sun, Xue-Li Yang, Meng-Ting Chen, Yang Liu, Yang Zhao, Yuan-Yuan Zhao, Wei Jin
Survival following radiotherapy in young women with localized early-stage breast cancer according to molecular subtypes. Cancer medicine 8 (6) (2019)